(Q39997217)

16 September 2017

In vitro and in vivo effectiveness of egg yolk antibody against Candida albicans (anti-CA IgY). (English)

1 reference

16 September 2017

1 reference

1 reference

El-Sayed Moustafa Ibrahim

1

1 reference

16 September 2017

A K M Shofiqur Rahman

2

1 reference

16 September 2017

Rie Isoda

3

1 reference

16 September 2017

Kouji Umeda

4

1 reference

16 September 2017

Nguyen Van Sa

5

1 reference

16 September 2017

Yoshikatsu Kodama

6

1 reference

16 September 2017

language of work or name

English

0 references

publication date

13 March 2008

1 reference

16 September 2017

1 reference

16 September 2017

26

1 reference

16 September 2017

17

1 reference

16 September 2017

2073-2080

1 reference

Gastric colonization of Candida albicans differs in mice fed commercial and purified diets

16 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.046

CD4(+)-T-Cell-mediated resistance to systemic murine candidiasis induced by a membrane fraction of Candida albicans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.046

Candida infection of the gastrointestinal tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.046

Disseminated candidiasis. Changes in incidence, underlying diseases, and pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.046

Animal models of oral candidiasis. A review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.046

Experimental oral candidiasis in animal models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.046

Effect of sialoadenectomy on the carriage of Candida albicans in the mouths of rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.046

Multiple resistant phenotypes of Candida albicans coexist during episodes of oropharyngeal candidiasis in human immunodeficiency virus-infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.046

A novel murine model of oral candidiasis with local symptoms characteristic of oral thrush

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.046

Virulence factors of Candida albicans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.046

Oral Candida: clearance, colonization, or candidiasis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.046

Fungal adherence to the vascular compartment: a critical step in the pathogenesis of disseminated candidiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.046

Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.046

Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.046

The role of hsp90 in fungal infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.046

Active and passive immunization against oral Candida albicans infection in a murine model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.046

Homing of naive, memory and effector lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.046

Passive protection against bovine rotavirus-induced diarrhea in murine model by specific immunoglobulins from chicken egg yolk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.046

Effect of oral egg antibody in experimental F18+ Escherichia coli infection in weaned pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.046

Oral passive immunization against experimental salmonellosis in mice using chicken egg yolk antibodies specific for Salmonella enteritidis and S. typhimurium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.046

Effect of dietary anti-urease immunoglobulin Y on Helicobacter pylori infection in Mongolian gerbils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.046

Activity of anti-Porphyromonas gingivalis egg yolk antibody against gingipains in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.046

Effects of egg yolk antibody against Porphyromonas gingivalis gingipains in periodontitis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.046

Identification of potential cell-surface proteins in Candida albicans and investigation of the role of a putative cell-surface glycosidase in adhesion and virulence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.046

Oral lactoferrin treatment of experimental oral candidiasis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.046

Effect of monoclonal antibodies on the colonization of rats by Streptococcus sobrinus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.046

Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.046

Characterization of the Porphyromonas gingivalis antigen recognized by a monoclonal antibody which prevents colonization by the organism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.046

Functional characteristics of antibodies induced by Arg-gingipain (HRgpA) and Lys-gingipain (Kgp) from Porphyromonas gingivalis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.046

Immunization by Arg-gingipain A DNA vaccine protects mice against an invasive Porphyromonas gingivalis infection through regulation of interferon-gamma production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.046

A novel family of cell wall-related proteins regulated differently during the yeast life cycle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.046

Virulence factors in Escherichia coli urinary tract infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.046

Protection of mice from lethal endogenous Candida albicans infection by immunization with Candida membrane antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.046

Oral and esophageal Candida albicans infection in hyposalivatory rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.046

inferred from DOI database lookup

7 January 2021

based on heuristic

Passive protective effect of chicken egg yolk immunoglobulins against experimental enterotoxigenic Escherichia coli infection in neonatal piglets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.046

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2008.02.046

1 reference

16 September 2017

1 reference